EDAP TMS S.A Common Stock Net 2010-2024 | EDAP
EDAP TMS S.A common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
| EDAP TMS S.A Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $5 |
| 2023 | $5 |
| 2022 | $5 |
| 2021 | $5 |
| 2020 | $4 |
| 2019 | $4 |
| 2018 | $5 |
| 2017 | $4 |
| 2016 | $4 |
| 2015 | $4 |
| 2014 | $4 |
| 2013 | $4 |
| 2012 | $3 |
| 2011 | $2 |
| 2010 | $2 |
| 2009 | $2 |
| EDAP TMS S.A Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2024-12-31 | $5 |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $4 |
| 2019-09-30 | |
| 2019-03-31 | |
| 2018-12-31 | $5 |
| 2018-09-30 | |
| 2018-06-30 | $5 |
| 2018-03-31 | |
| 2017-12-31 | $4 |
| 2017-09-30 | |
| 2017-06-30 | $4 |
| 2017-03-31 | |
| 2016-12-31 | $4 |
| 2016-09-30 | |
| 2016-06-30 | $4 |
| 2016-03-31 | |
| 2015-12-31 | $4 |
| 2015-09-30 | $0 |
| 2015-06-30 | $4 |
| 2015-03-31 | $0 |
| 2014-12-31 | $4 |
| 2014-09-30 | |
| 2014-06-30 | $4 |
| 2014-03-31 | |
| 2013-12-31 | $4 |
| 2013-09-30 | |
| 2013-06-30 | $4 |
| 2013-03-31 | |
| 2012-12-31 | $3 |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | $2 |
| 2011-09-30 | |
| 2011-06-30 | $3 |
| 2011-03-31 | |
| 2010-12-31 | $2 |
| 2010-09-30 | |
| 2010-06-30 | $2 |
| 2010-03-31 | |
| 2009-12-31 | $2 |
| 2009-09-30 | |
| 2009-06-30 | $2 |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.078B | $0.069B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.546B | 80.83 |
| Thermo Fisher Scientific (TMO) | United States | $161.389B | 19.52 |
| Alcon (ALC) | Switzerland | $47.559B | 31.61 |
| Edwards Lifesciences (EW) | United States | $44.842B | 29.34 |
| IDEXX Laboratories (IDXX) | United States | $35.412B | 40.95 |
| DexCom (DXCM) | United States | $27.957B | 43.21 |
| IQVIA Holdings (IQV) | United States | $27.056B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.200B | 25.88 |
| STERIS (STE) | Ireland | $22.012B | 25.17 |
| Waters (WAT) | United States | $20.277B | 28.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.073B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.659B | 14.96 |
| Hologic (HOLX) | United States | $13.095B | 14.13 |
| Sysmex ADR (SSMXY) | Japan | $11.834B | 0.00 |
| Penumbra (PEN) | United States | $11.498B | 90.25 |
| Globus Medical (GMED) | United States | $9.948B | 23.03 |
| Masimo (MASI) | United States | $8.815B | 36.99 |
| Teleflex (TFX) | United States | $6.409B | 9.87 |
| Glaukos (GKOS) | United States | $5.356B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.429B | 23.20 |
| TransMedics (TMDX) | United States | $3.126B | 91.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Veracyte (VCYT) | United States | $2.446B | 44.20 |
| Nihon Kohden (NHNKY) | Japan | $2.137B | 11.68 |
| LivaNova (LIVN) | United Kingdom | $2.047B | 12.43 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.638B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.340B | 6.78 |
| Pulse Biosciences (PLSE) | United States | $1.197B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.116B | 0.00 |
| Artivion (AORT) | United States | $1.024B | 95.96 |
| OPKO Health (OPK) | United States | $0.940B | 0.00 |
| AxoGen (AXGN) | United States | $0.732B | 0.00 |
| IRadimed (IRMD) | United States | $0.683B | 35.80 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 13.94 |
| RxSight (RXST) | United States | $0.619B | 0.00 |
| SiBone (SIBN) | United States | $0.607B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.41 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.551B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.523B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.476B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.443B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.410B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 18.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.326B | 6.92 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.198B | 0.00 |
| Inogen (INGN) | United States | $0.196B | 0.00 |
| 908 Devices (MASS) | United States | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.163B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 11.12 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |